Glaxosmithkline | 売上原価



Cost Of Sales 変化する 日付
AbbVie USD 4.35B 344M 2025-06
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.47B 232M 2025-06
Aurora Cannabis CAD 78.85M 891K 2024-12
Bausch Health Companies USD 764M 63M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 3.43M 1.03M 2025-06
Drreddys Laboratories INR 34.53B 2.14B 2024-12
Eli Lilly USD 2.45B 223.6M 2025-06
GlaxoSmithKline GBP 2.16B 241M 2025-06
Glaxosmithkline GBP 2.52B 199M 2024-12
J&J USD 7.6B 304M 2025-06
Merck USD 2.82B 53M 2025-06
Novartis USD 3.32B 95M 2025-06
Pacira USD 55.19M 20.88M 2025-06
Perrigo USD 693.4M 41.8M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Prestige Brands USD 114.38M 12.13M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.99B 103M 2025-06
Supernus Pharmaceuticals USD 37.65M 21.88M 2025-06
Takeda JPY 384.68B 2.6B 2025-06
Teva Pharmaceutical Industries USD 2.07B 97M 2025-06
Zoetis USD 682M 60M 2025-06


Glaxosmithkline 売上原価 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Aug 2025.